Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for February, 2010

Dual-filing feat a rarity for little guy

Wednesday, February 17th, 2010

You may have read recently about a small biotech outfit in New Jersey having successfully submitted simultaneous regulatory filings in the United States and Europe for Luveniq, a new oral treatment for non-infectious uveitis, an inflammatory condition of the eye that can lead to blindness (see the release here). You ...

Posted in Uncategorized, clinical trials, filed for approval | No Comments »

MicroRNAs may revolutionize NSCLC classification

Wednesday, February 3rd, 2010

Routine histophathology is the gold standard method of non-small cell lung cancer classification, but this method is considered unreliable, with poor reproducibility and low observer correlation. Studies show that when given the same sample, pathologists will disagree on the diagnosis in 30% to 40% of cases in classifying non-small cell ...

Posted in Uncategorized | No Comments »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2012 UBM Canon